Target intelligence / Profile preview

Alternative energy substrate (None established; not a standard molecular abbreviation.)

Target
None established; not a standard molecular abbreviation.
Molecular classification
Other (not an individual molecule), Metabolite (general class)
01

Overview

The term alternative energy substrate refers broadly to any metabolite that cells utilize for ATP generation when their preferred fuel—typically glucose—is insufficient or unavailable. Common examples include ketone bodies, fatty acids, and sometimes amino acids or lactate. This metabolic flexibility allows tissues such as the heart and brain to maintain function during periods of fasting, intense exercise, starvation, diabetes mellitus, or cardiac dysfunction. In clinical research and therapeutics—especially cardiology—modulating the availability or utilization of these alternative fuels has been explored as a strategy for supporting failing organs like the myocardium. However, "alternative energy substrate" itself does not denote any particular protein target amenable to direct pharmacological intervention—it describes a physiological phenomenon rather than an actionable drug target.

Other names
Alternative metabolic fuelNon-glucose energy sourceSecondary energy substrate
02

Mechanism of action

Not applicable for this entry; mechanisms depend on the specific alternative substrate and context.

03

Biological functions

Cellular ATP production during glucose scarcityMetabolic adaptation in fasting, exercise, heart failureMaintenance of cellular and organ function under stress
04

Disease associations

Cardiovascular disease (e.g., heart failure adaptation)Neurodegenerative disease (e.g., brain use of ketones in Alzheimer's)Diabetes mellitus and metabolic disordersOther conditions involving altered metabolism
05

Safety considerations

Excessive reliance on certain alternative substrates can have adverse effects—for example, ketoacidosis with high ketone body levels.Impaired ability to switch between substrates may contribute to disease progression in heart failure and diabetes.
06

Interacting drugs

Some drugs modulate the use of alternative substrates indirectly (e.g., SGLT2 inhibitors increase ketone body utilization in the heart).
07

Biomarkers

Blood levels of ketone bodiesFree fatty acidsLactate concentrations

Beyond the preview

Go deeper on Alternative energy substrate (None established; not a standard molecular abbreviation.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alternative energy substrate (None established; not a standard molecular abbreviation.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call